- Home
- BRLT vs AIMD Comparison
BRLT vs AIMD Comparison
Compare BRLT & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- AIMD
- Stock Information
- Founded
- BRLT 2005
- AIMD 1984
- Country
- BRLT United States
- AIMD United States
- Employees
- BRLT N/A
- AIMD N/A
- Industry
- BRLT Consumer Specialties
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- AIMD Health Care
- Exchange
- BRLT Nasdaq
- AIMD Nasdaq
- Market Cap
- BRLT 19.8M
- AIMD 16.9M
- IPO Year
- BRLT 2021
- AIMD N/A
- Fundamental
- Price
- BRLT $2.36
- AIMD $3.40
- Analyst Decision
- BRLT Hold
- AIMD
- Analyst Count
- BRLT 2
- AIMD 0
- Target Price
- BRLT $1.80
- AIMD N/A
- AVG Volume (30 Days)
- BRLT 306.9K
- AIMD 89.6K
- Earning Date
- BRLT 11-06-2025
- AIMD 11-05-2025
- Dividend Yield
- BRLT 10.50%
- AIMD N/A
- EPS Growth
- BRLT N/A
- AIMD N/A
- EPS
- BRLT N/A
- AIMD N/A
- Revenue
- BRLT $422,218,000.00
- AIMD $110,870.00
- Revenue This Year
- BRLT $5.55
- AIMD N/A
- Revenue Next Year
- BRLT $3.88
- AIMD N/A
- P/E Ratio
- BRLT N/A
- AIMD N/A
- Revenue Growth
- BRLT N/A
- AIMD 70.25
- 52 Week Low
- BRLT $1.25
- AIMD $2.00
- 52 Week High
- BRLT $3.10
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- BRLT 49.28
- AIMD 48.33
- Support Level
- BRLT $2.75
- AIMD $3.28
- Resistance Level
- BRLT $2.70
- AIMD $3.83
- Average True Range (ATR)
- BRLT 0.28
- AIMD 0.28
- MACD
- BRLT -0.07
- AIMD -0.06
- Stochastic Oscillator
- BRLT 26.00
- AIMD 12.64
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.